Literature DB >> 22276559

Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.

J Truong1, B J Levkovich, A A Padiglione.   

Abstract

BACKGROUND: Patients in the Intensive Care Unit (ICU) often have sub-therapeutic vancomycin levels in the initial stages of therapy. Loading doses have been demonstrated to overcome this problem. AIM: The aim of this study was to determine the impact of a standardised loading dose and increased clinician awareness of under-dosing on the achievement of early therapeutic vancomycin trough concentrations in the ICU.
METHODS: A pre- and post-intervention observational study was conducted in the ICU following the introduction of a 2-g vancomycin loading dose and demonstration of local under-dosing. All initial vancomycin trough levels were examined, except those from neurosurgical patients. Primary outcome measures were the proportion of patients achieving therapeutic vancomycin levels and mean trough concentrations. A year after introduction, a review was conducted to further assess the impact and sustainability of the intervention.
RESULTS: There were 31 courses of vancomycin in the pre-intervention period (no loading doses given) and 21 courses in the post-intervention period, of which 11 had a loading dose. In the pre-intervention group, 13% of courses achieved therapeutic concentrations. This increased to 33% in the post-intervention group (P= 0.08). A statistically significant increase in mean trough concentration, from 9.8 ± 6.6 mg/L to 14.9 ± 6.3 mg/L (P= 0.01), between the pre- and post-intervention groups was observed. During the follow-up period, results were similar to the post-intervention audit.
CONCLUSION: A standardised loading dose is a simple and sustainable intervention that may improve early achievement of therapeutic vancomycin levels in critically ill patients. The clinical significance of this requires further study.
© 2012 The Authors. Internal Medicine Journal © 2012 Royal Australasian College of Physicians.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22276559     DOI: 10.1111/j.1445-5994.2011.02459.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  17 in total

Review 1.  Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

Authors:  Andrew A Udy; Jason A Roberts; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-09-18       Impact factor: 17.440

2.  Selective vancomycin detection using optical fibre long period gratings functionalised with molecularly imprinted polymer nanoparticles.

Authors:  Sergiy Korposh; Iva Chianella; Antonio Guerreiro; Sarah Caygill; Sergey Piletsky; Stephen W James; Ralph P Tatam
Journal:  Analyst       Date:  2014-05-07       Impact factor: 4.616

3.  A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals.

Authors:  F M Buyle; J Decruyenaere; J De Waele; P M Tulkens; T Van Audenrode; P Depuydt; G Claeys; H Robays; D Vogelaers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-28       Impact factor: 3.267

Review 4.  Optimizing the Clinical Use of Vancomycin.

Authors:  Rocío Álvarez; Luis E López Cortés; José Molina; José M Cisneros; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

5.  Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients.

Authors:  Osvaldo Álvarez; Jose Cristian Plaza-Plaza; Manuel Ramirez; Alexis Peralta; Cristián A Amador; Roberto Amador
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

6.  Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.

Authors:  Kannan Sridharan; Amal Al Daylami; Reema Ajjawi; Husain Al-Ajooz; Sindhan Veeramuthu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

7.  Optimization of time to initial vancomycin target trough improves clinical outcomes.

Authors:  Anthony P Cardile; Christopher Tan; Michael B Lustik; Amy N Stratton; Cristian S Madar; Jun Elegino; Günther Hsue
Journal:  Springerplus       Date:  2015-07-19

8.  Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran.

Authors:  Afsaneh Vazin; Motahare Mahi Birjand; Masoud Darake
Journal:  Drug Healthc Patient Saf       Date:  2018-04-05

9.  The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries.

Authors:  Tijana Kovacevic; Branislava Miljkovic; Momir Mikov; Svjetlana Stojisavljevic Satara; Sasa Dragic; Danica Momcicevic; Pedja Kovacevic
Journal:  Dose Response       Date:  2019-05-20       Impact factor: 2.658

10.  Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study.

Authors:  Erin N Frazee; Andrew D Rule; Sandra M Herrmann; Kianoush B Kashani; Nelson Leung; Abinash Virk; Nikolay Voskoboev; John C Lieske
Journal:  Crit Care       Date:  2014-05-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.